SAS® Health and Life Sciences News SAS
Second Quarter 2009 www.sas.com  |  subscribe  |  unsubscribe
'New dawn' in healthcare »
An Internet-fueled shift to participatory healthcare, a growing focus on preventative medicine and wellness programs, advances in microbiology and genetics, and technology-enabled data exchange are transforming a system that soon will hardly resemble the one we know today.

Thought Leaders
Never mind the bolus »
As the US government ponders fundamental -- and costly -- shifts in the nation's healthcare system, leaders in Washington and in the industry's boardrooms must invest in analytical insights and change programs -- not just more data. So writes Jason Burke in his blog, "A Shot in the Arm."
Providing the right care ... right now »
SAS Business Solutions Manager Chris Scheib writes that the ability to intervene and provide the right care for the right patients at the right time is growing more critical than ever in the healthcare industry. Business analytics, especially predictive modeling, provides the right insights needed to make tough decisions that protect patients and health plans alike. 
Focus shifts from financials to clinical data »
Since the turn of the new century, the healthcare industry has spent less time focusing on financial data and more time collecting, integrating and understanding clinical data, says SAS Chief Healthcare Strategist Cindy Berry.
Industry News
Article touts SAS® OnDemand: Drug Development »
In a recent piece in ClinPage, David Handelsman, a SAS Business Solutions Manager, highlights the latest SAS software as a service offering.
Move to EHRs full of challenges »
A speaker at the SAS Health and Life Sciences Executive Conference says the transition to electronic health records won't be easy. Also, Jason Burke, Director of the Health and Life Sciences Global Practice, tells a TV reporter that slim travel budgets didn't hurt attendance at this year's conference -- a sure sign of its growing prominence. 
Double exposure »
SAS gets double exposure in a recent issue of PharmaVoice. Jason Burke, Director of the Health & Life Sciences Global Practice, was featured among industry thought leaders giving their perspective on what it means to be global. Also, SAS was featured in the article “Using Technology to Create Efficient Processes for Drug Development.”
Life sciences invests in analytics »
Despite the recession, pharmaceutical and biotech companies continue to invest in discovery and development of advanced, life-saving therapies. Small and midsize life science firms leading the quest to deliver innovative products use SAS analytics to speed drug development and facilitate regulatory compliance.
Shire picks SAS® Drug Development »
Shire, the global specialty biopharmaceutical company, has selected SAS® Drug Development as the platform for its clinical trials data.

Customer Success
Avantas boasts better forecasting »
Avantas can now forecast a hospital's staffing needs in a fraction of the time it formerly took and with a double-digit improvement in accuracy.
Getting drugs to market faster »
Vertex Pharmaceuticals saves millions using SAS® for clinical trial simulations.
CareSource holds down costs, helps patients with SAS® »
CareSource streamlines the integration, analysis and reporting needed to create an effective patient management system, which saves money and helps patients stay healthier.
Resources
How healthy is your data? »
Healthcare data can be diverse and complicated, the need for accurate data is critical. Improve the effectiveness and the efficiency of your data with Health Care Data and the SAS System.  Register today for the July 13-14 course in Irvine and bring a friend for free with our July 2-for-1 training offer!

SAS® in Designing Clinical Trials »
View this free Webinar led by Alex Dmitrienko, Ph.D., Principal Research Scientist at Eli Lilly and Company, author and award-winning continuing-education presenter.
Pharmaceutical Statistics Using SAS®: A Practical Guide »
This book introduces a range of data analysis problems encountered in drug development and illustrates them using case studies from actual pre-clinical experiments and clinical studies. It includes a discussion of methodological issues, practical advice from subject-matter experts and a review of relevant regulatory guidelines.
Support
Quick Links
SAS® solutions for SMBs »
Industry Solutions »
Recent Awards »
SAS News »
HLS newsletter archive »
 
Don't miss important updates from SAS! Please add sas.com as a domain
in your safe sender list.

Contact Us
Have questions, feedback or suggestions for SAS Health and Life Sciences News? Please e-mail us at hlseditor@sas.com.

 
SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration. Other brand and product names are trademarks of their respective companies. Copyright © 2009 SAS Institute Inc. All rights reserved.
Tech Support | Privacy Statement